Published in Cancer Causes Control on March 17, 2015
Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012. Cancer Causes Control (2015) 0.88
Forward. The reach and health impacts of the national breast and cervical cancer early detection program. Cancer Causes Control (2015) 0.86
Preventing premature deaths from breast and cervical cancer among underserved women in the United States: insights gained from a national cancer screening program. Cancer Causes Control (2015) 0.83
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
THE OREGON HEALTH INSURANCE EXPERIMENT: EVIDENCE FROM THE FIRST YEAR. Q J Econ (2012) 5.98
Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 4.64
Effect of cost sharing on screening mammography in Medicare health plans. N Engl J Med (2008) 4.48
Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer (2013) 2.14
Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care (2008) 2.11
Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control (2006) 2.02
Health care reform and women's insurance coverage for breast and cervical cancer screening. Prev Chronic Dis (2012) 1.56
Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012. Cancer Causes Control (2015) 1.48
Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning. Cancer (2014) 1.47
Mammography rates after the 2009 US Preventive Services Task Force breast cancer screening recommendation. Prev Med (2012) 1.42
The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography. J Am Coll Radiol (2013) 1.29
Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med (2011) 1.21
Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s. PLoS One (2014) 1.17
Cancer screening and age in the United States and Europe. Health Aff (Millwood) (2009) 1.03
Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012. Cancer Causes Control (2015) 0.88
Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology (2004) 3.22
Can we predict the outcomes of national colorectal cancer screening and can predictions help us plan? Gastroenterology (2005) 2.91
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer (2006) 2.42
Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control (2006) 2.02
Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005. Am J Public Health (2009) 1.90
Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. J Am Acad Dermatol (2011) 1.76
The effect of HIFA waiver expansions on uninsurance rates in adult populations. Health Serv Res (2012) 1.51
Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012. Cancer Causes Control (2015) 1.48
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion (2013) 1.43
HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr (2002) 1.37
Systems strategies to support cancer screening in U.S. primary care practice. Cancer Epidemiol Biomarkers Prev (2011) 1.28
Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology (2006) 1.27
Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care (2010) 1.24
Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med (2011) 1.21
Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control (2010) 1.20
Development of a federally funded demonstration colorectal cancer screening program. Prev Chronic Dis (2008) 1.19
Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 1.16
On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol (2007) 1.14
Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. World J Urol (2010) 1.12
Consequences of conversion in laparoscopic colorectal surgery. Dis Colon Rectum (2006) 1.10
State-level projections of cancer-related medical care costs: 2010 to 2020. Am J Manag Care (2012) 1.06
Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs. Prev Chronic Dis (2008) 1.05
Data sources for identifying low-income, uninsured populations: application to public health-National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 1.03
A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol (2002) 1.02
Health insurance and other factors associated with mammography surveillance among breast cancer survivors: results from a national survey. Med Care (2012) 1.02
Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes Control (2012) 1.02
Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. Cancer Causes Control (2015) 1.01
Prayer and self-reported health among cancer survivors in the United States, National Health Interview Survey, 2002. J Altern Complement Med (2008) 1.01
The in vivo pediculicidal efficacy of a natural remedy. Isr Med Assoc J (2002) 0.99
Repellency of citronella for head lice: double-blind randomized trial of efficacy and safety. Isr Med Assoc J (2004) 0.98
Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt) (2012) 0.98
Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J (2011) 0.98
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU Int (2011) 0.98
Cognitive function in adults with type 2 diabetes and major depression. Arch Clin Neuropsychol (2006) 0.95
International guidelines for effective control of head louse infestations. J Drugs Dermatol (2007) 0.94
Characteristics of US counties with no mammography capacity. J Community Health (2012) 0.94
The effect of race and rural residence on prostate cancer treatment choice among men in Georgia. Urology (2011) 0.93
Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer (2013) 0.92
Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis. Cancer (2013) 0.92
Factors associated with self-reported mammography use for women with and women without a disability. J Womens Health (Larchmt) (2011) 0.91
Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer (2013) 0.90
Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program. Cancer (2008) 0.90
Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet Med (2002) 0.88
Breast and cervical cancers diagnosed and stage at diagnosis among women served through the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.88
Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012. Cancer Causes Control (2015) 0.88
The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiority study. Hum Vaccin Immunother (2012) 0.88
Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study. BMC Infect Dis (2013) 0.87
Forward. The reach and health impacts of the national breast and cervical cancer early detection program. Cancer Causes Control (2015) 0.86
A comparative analysis of breast cancer stage between women enrolled in the National Breast and Cervical Cancer Early Detection Program and women not participating in the program. Cancer Causes Control (2015) 0.86
Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs. Cancer (2013) 0.84
Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood. Mutat Res (2004) 0.84
Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts. Cancer (2013) 0.84
Choropleth map design for cancer incidence, part 1. Prev Chronic Dis (2009) 0.83
The investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) and the seasonal influenza virus vaccine are immunogenic and well-tolerated when co-administered in adults. Hum Vaccin Immunother (2012) 0.82
Choropleth map design for cancer incidence, part 2. Prev Chronic Dis (2009) 0.82
Population-based study of trends, costs, and complications of weight loss surgeries from 1990 to 2002. Obes Res (2005) 0.82
Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs. Eval Program Plann (2010) 0.81
A combined approach to women's health is associated with a greater likelihood of repeat mammography in a population of financially disadvantaged women. Prev Chronic Dis (2007) 0.81
Enhancing screening and early detection among women transitioning to Medicare from the NBCCEDP in Georgia. Cancer Causes Control (2015) 0.81
Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population. Int J Gen Med (2011) 0.81
Assessment of the status of a National Action Plan for Cancer Survivorship in the USA. J Cancer Surviv (2013) 0.81
The effect of adult HIFA waiver expansions on insurance coverage of children. Med Care Res Rev (2012) 0.81
Establishment of an Ebola Treatment Unit and Laboratory - Bombali District, Sierra Leone, July 2014-January 2015. MMWR Morb Mortal Wkly Rep (2015) 0.80
Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective. Support Care Cancer (2013) 0.79
Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance. Cancer Causes Control (2015) 0.79
Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences. J Sex Med (2013) 0.79
Erratum to: Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012. Cancer Causes Control (2015) 0.79
The role of social support in posttreatment surveillance among African American survivors of colorectal cancer. J Psychosoc Oncol (2014) 0.78
Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study. Eur J Pediatr (2013) 0.78
Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program. Cancer (2013) 0.78